40228711000001108: Sotrovimab (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 11-May 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1914141000001116 Sotrovimab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1914151000001118 Sotrovimab (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Sotrovimab	Is a	Monoclonal antibody	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Sotrovimab 500mg/8ml solution for infusion vials	Has specific active ingredient	False	Sotrovimab	Inferred relationship	Existential restriction modifier
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd)	Has specific active ingredient	False	Sotrovimab	Inferred relationship	Existential restriction modifier
Sotrovimab 500mg/8ml solution for infusion vials 1 vial	Has specific active ingredient	False	Sotrovimab	Inferred relationship	Existential restriction modifier
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial	Has specific active ingredient	False	Sotrovimab	Inferred relationship	Existential restriction modifier
Xevudy 500mg/8ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial	Has specific active ingredient	False	Sotrovimab	Inferred relationship	Existential restriction modifier
Xevudy 500mg/8ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd)	Has specific active ingredient	False	Sotrovimab	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets